Serina Therapeutics Advances Once-Weekly Injectable VMAT2 …
Jul 29, 2025 · Serina also plans to explore development of POZ-VMAT2i for chorea associated with Huntington’s disease, a neurodegenerative disorder marked by progressive movement impairment …
Chorea Treatment Strategies | Practical Neurology
Chorea that interferes with activities of daily living (eg, the ability to dress, eat, chew, or attend to personal hygiene effectively) likely requires treatment. Chorea can cause safety concerns or physical …
Serina Therapeutics Advances POZ-VMAT2i for Tardive Dyskinesia and ...
Jul 29, 2025 · The once-weekly injectable VMAT2 inhibitor is designed to address adherence, access, and administration barriers in underserved TD patients. Serina also plans to explore development in …
Chorea: What It Is, Causes, Treatment & Risk Factors
What is chorea? Chorea is a symptom that causes involuntary, irregular or unpredictable muscle movements. It affects your arms, legs and facial muscles. Chorea comes from the Greek word that …
Serina Therapeutics Advances POZ-VMAT2i into Development for …
Jul 29, 2025 · Serina also plans to explore development of POZ-VMAT2i for chorea associated with Huntington’s disease, a neurodegenerative disorder marked by progressive movement impairment …
SER Press Release: Serina Therapeutics Advances POZ-VMAT2i into D...
Jul 29, 2025 · A weekly injectable therapy may offer meaningful advantages over current oral options for this population and their caregivers. "POZ-VMAT2i embodies Serina's commitment to solving real …
2025 Schizophrenia Insights: Ending the Year With Positive Data
6 days ago · Valbenazine is a selective VMAT2 inhibitor approved by the US FDA for the treatment of adults with TD and the treatment of chorea associated with Huntington disease. 2 Valbenazine offers …
Serina Therapeutics Unveils Weekly Injectable To Tackle $3.7B Tardive ...
Jul 29, 2025 · A weekly injectable therapy may offer meaningful advantages over current oral options for this population and their caregivers. "POZ-VMAT2i embodies Serina's commitment to solving real …
How Ingrezza Works for Tardive Dyskinesia and Chorea - WebMD
Aug 17, 2024 · How Does It Work for Tardive Dyskinesia and Chorea? Tardive dyskinesia (TD) is a condition that causes stiff, jerky movements that you cannot control and can affect your face and body.
Chorea associated with Huntington’s disease and Tardive dyskinesia The safety and effectiveness of Austedo have not been established in pediatric patients for the treatment of chorea associated with …